Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Lam

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Pharmacokinetics|November 1, 1992
Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectivesA H Lau, N P Lam, S C Piscitelli, et al.
Digestive Diseases and Sciences|January 1, 1997
Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis CN P Lam, D Pitrak, R Speralakis, et al.
Archives of Oral Biology|November 28, 2006
Age-dependent increase of discoidin domain receptor 2 and matrix metalloproteinase 13 expression in temporomandibular joint cartilage of type IX and type XI collagen-deficient miceN P Lam, Y Li, A B Waldman, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaN P Lam, A U Neumann, D R Gretch, et al.
Epilepsia|April 1, 1997
Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic functionA H Lau, L E Gustavson, R Sperelakis, et al.
Science (New York, N.Y.)|October 2, 1998
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapyA U Neumann, N P Lam, H Dahari, et al.
The Journal of Infectious Diseases|July 7, 2000
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virusA U Neumann, N P Lam, H Dahari, et al.
Clinical Therapeutics|July 1, 1997
Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trialsS X Kong, S Y Crawford, S K Gandhi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Pharmacokinetics|November 1, 1992
Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectivesA H Lau, N P Lam, S C Piscitelli, et al.
Digestive Diseases and Sciences|January 1, 1997
Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis CN P Lam, D Pitrak, R Speralakis, et al.
Archives of Oral Biology|November 28, 2006
Age-dependent increase of discoidin domain receptor 2 and matrix metalloproteinase 13 expression in temporomandibular joint cartilage of type IX and type XI collagen-deficient miceN P Lam, Y Li, A B Waldman, et al.
Hepatology (Baltimore, Md.)|July 1, 1997
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaN P Lam, A U Neumann, D R Gretch, et al.
Epilepsia|April 1, 1997
Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic functionA H Lau, L E Gustavson, R Sperelakis, et al.
Science (New York, N.Y.)|October 2, 1998
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapyA U Neumann, N P Lam, H Dahari, et al.
The Journal of Infectious Diseases|July 7, 2000
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virusA U Neumann, N P Lam, H Dahari, et al.
Clinical Therapeutics|July 1, 1997
Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trialsS X Kong, S Y Crawford, S K Gandhi, et al.
Pageof 2